Studies on Therapeutic Activity of Benzoxazinorifamycin KRM-1648 in Combination with Other Antimicrobial Agents and Biological Response Modifiers Interferon-γ and Granulocyte-Macrophage Colony-Stimulating Factor Against M. leprae Infection in Athymic Nude Mice

International Journal of Leprosy and Other Mycobacterial Diseases

Volumn 65, Issue 3, 1997, Pages 345-351

  Maw, Win Win ^a   Tomioka, Haruaki ^a   Sato, Katsumasa ^a   Saito, Hajime ^b  

^a SHIMANE UNIVERSITY   (Japan)

^b National Institute Leprosy Research   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CLOFAZIMINE; DAPSONE; LEPROSTATIC AGENT; OFLOXACIN; RECOMBINANT GAMMA INTERFERON; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RIFALAZIL; RIFAMPICIN; RIFAMYCIN DERIVATIVE;

ANIMAL MODEL; ARTICLE; DRUG EFFICACY; EXPERIMENTAL INFECTION; FEMALE; INTRAMUSCULAR DRUG ADMINISTRATION; LEPROSY; MYCOBACTERIOSIS; MYCOBACTERIUM LEPRAE; NONHUMAN; NUDE MOUSE; ORAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADOPTIVE TRANSFER; ANIMALS; BIOLOGICAL RESPONSE MODIFIERS; CLOFAZIMINE; DAPSONE; DRUG THERAPY, COMBINATION; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; INTERFERON TYPE II; LEPROSTATIC AGENTS; LEPROSY; MICE; MICE, INBRED BALB C; MICE, NUDE; OFLOXACIN; RIFAMYCINS;

EID: 0030657978     PISSN: 0148916X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. BARNES, P. F., MODLIN, R. L., and ELLNER, J. J. T-cell responses and cytokines. In: Tuberculosis; Pathogenesis, Protection, and Control. Bloom, B. R., ed. Washington, D.C.: American Society for Microbiology, 1994, pp. 417-435.
2. BERMUDEZ, L. E. and KAPLAN. G. Recombinant cytokines for controlling mycobacterial infections. Trends Microbiol. 3 (1995) 22-27.
3. CHAN, J. and KAUFMANN, S. H. E. Immune mechanisms of protection. In: Tuberculosis; Pathogenesis, Protection and Control. Bloom, B. R., ed. Washington, D.C.: American Society for Microbiology, 1994, pp. 389-415.
4. CHAN, J., XING, Y., MAGLIOZZO, R. S. and BLOOM, B. R. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J. Exp. Med. 175 (1992) 1111-1122.
5. DING, A. H., NATHAN, C. F. and STUEHR, D. J. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages; comparison of activating cytokines and evidence for independent production. J. Immunol. 141 (1988) 2407-2412.
6. GASSON, J. C. Molecular physiology of granulocyte-macrophage colony-stimulating factor. Blood 77 (1991) 1131-1145.
7. GODFREY, K. Statistics in practice; comparing the means of several groups. New Engl. J. Med. 313 (1985) 1450-1456.
8. HO, J. L., HE, S. H., RIOS, M. J. C. and WICK, E. A. Interleukin-4 inhibits human macrophage activation by tumor necrosis factor, granulocyte-monocyte colony-stimulating factor, and interleukin-3 for antileishmanial activity and oxidative burst capacity. J. Infect. Dis. 165 (1992) 344-351.
9. KATOCH, K., RAMU, G., RAMANATHAN, U., SENGUPTA, U., SREEVASTA, SHARMA, V.D., SHIVANNAVAR, C. T., and KATOCH, V. M. Results of a modified WHO regimen in highly bacilliferous BL/LL patients. Int. J. Lepr. 57 (1989) 451-457.
10. KAUFMANN, S. H. E. Cell-mediated immunity. In: Leprosy. 2nd edn., Hastings, R. C., ed. Edinburgh: Churchill Livingstone, 1994, pp. 157-168.
11. + T lymphocytes in intracellular microbial infections, Immunol. Today 9 (1988) 168-174.
12. + T cells in the expression of host resistance to Mycobacterium leprae infection induced in athymic nude mice. Int. J. Lepr. 63 (1995) 539-545.
13. MOSMANN, T. R., CHEWINSKI, H., BOND, M. W., GIEDLIN, M. A. and COFFMAN, R. L. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136 (1986) 2348-2357.
14. MOSMANN, T. R., and MOORE, K. W. The role of IL-10 in crossregulation of Th1 and Th2 responses. Immunol. Today 12 (1991) A49-53.
15. MURRAY, H. W. Interferon-gamma, the activated macrophage, and host defense against microbial challenge. Ann. Intern. Med. 108 (1988) 595-608.
16. MURRAY, H. W. Gamma interferon, cytokine-induced macrophage activation, and antimicrobial host defense in vitro, in animal models, and in humans, Diagn. Microbiol. Infect. Dis. 13 (1990) 411-421.
17. NISHINO, T., IKEDA Y., OTSUKI, M., HAYASHI, H. and IMANISHI, R. In vitro and in vivo antimicrobial activities of pazufloxacin, a new synthetic antimicrobial agent. Chemotherapy 43 S-2 (1995) 54-65.
18. SAITO, H., TOMIOKA, H. and SATO, K. Purification of M. leprae with special reference to the effects of purified M. leprae vaccines on host macrophage cell functions. Jpn. J. Lepr. 56 (1987) 101-109.
19. SAITO, H., TOMIOKA, H. and SATO, K. In vivo anti-M. leprae activity of benzoxazinorifamycin, KRM-1648, in combination with other antimicrobials. Proceedings of Twenty-Ninth Joint Conference on Tuberculosis and Leprosy, Washington, D.C.: U.S.-Japan Cooperative Medical Science Program, 1994, pp. 228-233.
20. SAITO, H., TOMIOKA, H., SATO, K. and DEKIO, S. Therapeutic efficacy of benzoxazinorifamycin, KRM-1648, in combination with other antimicrobials against Mycobacterium leprae infection in-duced in nude mice. Int. J. Lepr. 62 (1994) 43-47.
21. SALGAME, P., ABRAMS, J. S., CLAYBERGER, C., GOLDSTEIN, H., CONVIT, J., MODLIN, R. L. and BLOOM, B. R. Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science 254 (1991) 279-282.
22. SHANNON, E. J., CHEHL, S., Job, C. K. and HASTINGS, R. C. Adoptively transferred reactivity to M. leprae in nude mice infected with M. leprae. Clin. Exp. Immunol. 70 (1987) 279-282.
23. SHEPARD, C. C. The experimental disease that follows the injection of human leprosy bacilli into footpads of mice. J. Exp. Med. 112 (1960) 445-454.
24. SIELING, P. A., ABRAMS, J. S., YAMAMURA, M., SALGAME, P., BLOOM, B. R., REA, T. H. and MODLIN, R. L. Immunosuppressive roles for TL-10 and IL-4 in human infection; in vitro modulation of T cell responses in leprosy. J. Immunol. 150 (1993) 5501-5510.
25. TACHIZAWA, H., TSUMURA, M., UNE, T. and SATO, K. Phase I study on DL-8280. Chemotherapy 32 S-1 (1984) 118-149.
26. TOMIOKA, H. and SAITO, H. Therapeutic efficacy of some new quinolones and a combination of ofloxacin with rifampin against Mycobacterium leprae infection induced in athymic nude mice. Int. J. Lepr. 61 (1993) 250-254.
27. TOMIOKA, H. and SAITO, H. In vivo, antileprosy activity of the newly synthesized benzoxazinorifamycin. KRM-1648. Int. J. Lepr. 61 (1993) 255-258.
28. WHO STUDY GROUP. Chemotherapy of leprosy for control programmed. Geneva: World Health Organization, 1982. Tech. Rep. Ser. 675.